A number of technologies and tools got a chance to prove themselves for the first time in the context of Covid-19. Three researchers working in gene-based vaccines, wearable diagnostics and drug discovery explain how their work rose to the challenge of the pandemic, and their hopes that each technology is now poised to continue making big changes in medicine.
Genetic vaccines
Deborah Fuller, Professor of Microbiology at the University of Washington.
Thirty years ago, researchers for the first time injected mice with genes from a foreign pathogen to produce an immune response. Like many new discoveries, these first gene-based vaccines had their ups and downs. Early mRNA vaccines were hard to store and did not produce the right type of immunity. DNA vaccines were more stable but were not efficient at getting into the cell’s nucleus, so they failed to produce sufficient immunity.
Researchers slowly overcame the problems of stability, getting the genetic instructions where…
